Therachon therachon.com

Therachon is a biotechnology company focused on developing treatments for rare, genetic diseases that currently have no available treatments. The company's lead pipeline candidate, TA-46, is a protein therapy in development for achondroplasia, the most common form of short-limbed dwarfism.

Therachon is a biotechnology company focused on developing treatments for rare, genetic diseases that currently have no available treatments. The company's lead pipeline candidate, TA-46, is a protein therapy in development for achondroplasia, the mo...Show all

See All Exits Recent Exits

Phone:

Fax:

Aeschenvorstadt 36

Basel, 4051
Switzerland

Therachon - Investments & Acquisitions

Show Real Data Therachon Investments
See all Recent Investments
Date Company Round Amount Co-investors
2018-10-09GlyPharma TherapeuticAcquired
See all 1 investments